Sprint Bioscience AB (publ) (STO: SPRINT)
Sweden
· Delayed Price · Currency is SEK 1.240
0.00 (0.00%)
Sep 11, 2024, 5:00 PM CET
Sprint Bioscience AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 85.01 | 50.49 | 0.08 | 35.11 | 16.89 | 33.54 | Upgrade
|
| Other Revenue | 1.2 | 1.2 | - | -0.09 | 2.31 | 0.27 | Upgrade
|
| Revenue | 86.21 | 51.69 | 0.08 | 35.03 | 19.2 | 33.81 | Upgrade
|
| Revenue Growth (YoY) | 141234.43% | 62171.08% | -99.76% | 82.49% | -43.23% | 88.51% | Upgrade
|
| Cost of Revenue | 19.97 | 8.7 | 12.93 | 10.44 | 10.46 | 8.17 | Upgrade
|
| Gross Profit | 66.24 | 42.99 | -12.85 | 24.59 | 8.74 | 25.64 | Upgrade
|
| Selling, General & Admin | 51.9 | 45.07 | 47.44 | 49.47 | 45.71 | 45.33 | Upgrade
|
| Other Operating Expenses | -0.71 | -1.21 | -0.29 | - | - | - | Upgrade
|
| Operating Expenses | 51.95 | 44.31 | 47.77 | 50.06 | 46.41 | 46.07 | Upgrade
|
| Operating Income | 14.29 | -1.32 | -60.62 | -25.47 | -37.68 | -20.43 | Upgrade
|
| Interest Expense | - | - | -0 | -0.27 | -3.44 | -1.21 | Upgrade
|
| Interest & Investment Income | 1.18 | 0.79 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.09 | 0.09 | 0.45 | 0.69 | -1.08 | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.84 | - | -0 | -0.04 | -0.6 | - | Upgrade
|
| EBT Excluding Unusual Items | 14.72 | -0.44 | -60.17 | -25.08 | -42.79 | -21.55 | Upgrade
|
| Asset Writedown | - | - | - | - | - | 0.01 | Upgrade
|
| Pretax Income | 14.72 | -0.44 | -60.17 | -25.08 | -42.79 | -21.54 | Upgrade
|
| Net Income | 14.72 | -0.44 | -60.17 | -25.08 | -42.79 | -21.54 | Upgrade
|
| Net Income to Common | 14.72 | -0.44 | -60.17 | -25.08 | -42.79 | -21.54 | Upgrade
|
| Shares Outstanding (Basic) | 70 | 70 | 42 | 29 | 17 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 70 | 70 | 42 | 29 | 17 | 11 | Upgrade
|
| Shares Change (YoY) | 22.41% | 65.98% | 45.85% | 71.85% | 49.55% | 26.97% | Upgrade
|
| EPS (Basic) | 0.21 | -0.01 | -1.43 | -0.87 | -2.55 | -1.92 | Upgrade
|
| EPS (Diluted) | 0.21 | -0.01 | -1.43 | -0.87 | -2.55 | -1.92 | Upgrade
|
| Free Cash Flow | 20.73 | 20.42 | -59.05 | -42.82 | -32.22 | -28.1 | Upgrade
|
| Free Cash Flow Per Share | 0.30 | 0.29 | -1.40 | -1.48 | -1.92 | -2.50 | Upgrade
|
| Gross Margin | 76.84% | 83.17% | - | 70.21% | 45.51% | 75.82% | Upgrade
|
| Operating Margin | 16.58% | -2.56% | -73031.33% | -72.70% | -196.28% | -60.43% | Upgrade
|
| Profit Margin | 17.07% | -0.85% | -72493.98% | -71.61% | -222.93% | -63.70% | Upgrade
|
| Free Cash Flow Margin | 24.04% | 39.50% | -71149.40% | -122.26% | -167.87% | -83.10% | Upgrade
|
| EBITDA | 15.06 | -0.88 | -60 | -24.88 | -36.98 | -19.69 | Upgrade
|
| EBITDA Margin | 17.46% | -1.69% | - | -71.02% | -192.64% | -58.24% | Upgrade
|
| D&A For EBITDA | 0.77 | 0.45 | 0.62 | 0.59 | 0.7 | 0.74 | Upgrade
|
| EBIT | 14.29 | -1.32 | -60.62 | -25.47 | -37.68 | -20.43 | Upgrade
|
| EBIT Margin | 16.58% | -2.56% | - | -72.70% | -196.28% | -60.43% | Upgrade
|
| Revenue as Reported | 88 | 54.32 | 0.45 | 35.07 | 19.61 | 34.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.